Varian to Distribute Innova Vascular’s Thrombectomy Solutions

May 15, 2024—Varian, a Siemens Healthineers company, announced an exclusive United States distribution agreement with Innova Vascular, Inc. Innova is a developer of minimally invasive devices for treating vascular disease, including its Laguna thrombectomy system, which is designed to treat venous thromboembolism.

According to Varian, the Laguna system consists of the Malibu aspiration catheter system and Laguna clot retriever system, which received FDA 510(k) clearance in June 2023. The system enables treatment of a wide range of patients and clot morphologies.

“The Laguna thrombectomy system stands out as a significant enhancement to the current treatment options available for venous thromboembolism,” commented John Moriarty, MD, in the company’s press release. “The flexibility of the aspiration catheter and clot retriever coupled together with its user-friendly design will empower operators of diverse skill levels to effectively clear clots in critical patients.” Dr. Moriarty is Professor of Interventional Radiology and Cardiology and Vice Chair of Clinical Research at UCLA in Los Angeles, California.

Varian advised that “Early Clinical Experience of the Laguna Thrombectomy System” will be presented on May 17 by Bulent Arslan, MD, at GEST 2024, the Global Embolization Symposium and Technology held May 16-19 in New York. New York. Dr. Arslan is Professor and Chair, Vascular and Interventional Service Lines at Rush University Medical Center in Chicago, Illinois.